Suppr超能文献

III型黏多糖贮积症的中晚期行为表型研究。

An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-III.

作者信息

Cross Elaine M, Grant Sheena, Jones Simon, Bigger Brian W, Wraith James E, Mahon Louise V, Lomax Michelle, Hare Dougal J

机构信息

Section for Clinical and Health Psychology, School of Psychological Sciences, University of Manchester, Zochonis Building, Brunswick Street, Manchester, M13 9PL UK.

Department of Genetic Medicine, St Mary's Hospital, Manchester, UK.

出版信息

J Neurodev Disord. 2014;6(1):46. doi: 10.1186/1866-1955-6-46. Epub 2014 Dec 31.

Abstract

BACKGROUND

Mucopolysaccharidosis type-III (MPS III) is an autosomal recessive lysosomal storage disorder. It causes progressive physical and cognitive decline and has been linked to increased incidences of behavioural problems.

METHODS

Data on the behaviour and adaptive skills of 20 children with MPS III and 25 children with intellectual disability (ID) (17 included in analysis) were gathered via parental report questionnaire. The frequencies of different types of behaviour displayed by children with MPS III and children with ID were compared across two age categories.

RESULTS

The total frequency of challenging behaviours displayed by children aged 2-9 years with MPS III and ID was not significantly different. Behaviours associated with hyperactivity, orality, unusual body movements and inattention were seen significantly more frequently in 2-9 year olds with MPS III than in those with ID. Children aged 10-15 years with MPS III showed significantly fewer problem behaviours than a contrasting group with ID. The frequency of challenging behaviours displayed by children with MPS III and their adaptive skills was found to decrease with age.

CONCLUSIONS

Behaviours relating to hyperactivity, orality, unusual body movements and inattention are part of the behavioural phenotype of the middle phase of MPS III. The late phase of MPS III is associated with low rates of problem behaviour and loss of adaptive skills. Therefore, families with a child with MPS III may benefit from a different type of clinical service when the child is aged 2-9 years, than when aged 10-15 years.

摘要

背景

Ⅲ型黏多糖贮积症(MPS III)是一种常染色体隐性溶酶体贮积症。它会导致身体和认知能力逐渐衰退,并与行为问题发生率增加有关。

方法

通过家长报告问卷收集了20名患有MPS III的儿童和25名智力残疾(ID)儿童(分析中纳入17名)的行为和适应技能数据。比较了MPS III患儿和ID患儿在两个年龄组中表现出的不同类型行为的频率。

结果

2至9岁的MPS III患儿和ID患儿表现出的挑战性行为的总频率没有显著差异。在2至9岁的MPS III患儿中,与多动、口部行为、异常身体动作和注意力不集中相关的行为比ID患儿中更频繁出现。10至15岁的MPS III患儿表现出的问题行为明显少于与之对比的ID组。发现MPS III患儿表现出的挑战性行为频率及其适应技能随年龄增长而降低。

结论

与多动、口部行为、异常身体动作和注意力不集中相关的行为是MPS III中期行为表型的一部分。MPS III后期与低问题行为发生率和适应技能丧失有关。因此,患有MPS III患儿的家庭在孩子2至9岁时可能比在10至15岁时受益于不同类型的临床服务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb17/4318134/8c8c1922e455/11689_2013_94_Fig1_HTML.jpg

相似文献

1
An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-III.
J Neurodev Disord. 2014;6(1):46. doi: 10.1186/1866-1955-6-46. Epub 2014 Dec 31.
4
What Can We Learn from the Parents of Children Affected with Mucopolysaccharidosis Type III-A in Israel?
Mol Syndromol. 2022 Feb;13(1):45-49. doi: 10.1159/000519099. Epub 2021 Dec 15.
5
Challenging symptoms in children with rare life-limiting conditions: findings from a prospective diary and interview study with families.
Acta Paediatr. 2012 Sep;101(9):985-92. doi: 10.1111/j.1651-2227.2012.02680.x. Epub 2012 May 24.
6
Social Functioning and Behaviour in Mucopolysaccharidosis IH [Hurlers Syndrome].
JIMD Rep. 2018;39:75-81. doi: 10.1007/8904_2017_47. Epub 2017 Jul 29.
9
From hypertransaminasemia to mucopolysaccharidosis IIIA.
Ital J Pediatr. 2014 Dec 2;40:97. doi: 10.1186/s13052-014-0097-z.

引用本文的文献

1
Disease progression in Sanfilippo type B: Case series of Brazilian patients.
Genet Mol Biol. 2024 Mar 8;47(1):e20230285. doi: 10.1590/1678-4685-GMB-2023-0285. eCollection 2024.
2
Psychobehavioral factors and family functioning in mucopolysaccharidosis: preliminary studies.
Front Public Health. 2024 Jan 24;12:1305878. doi: 10.3389/fpubh.2024.1305878. eCollection 2024.
3
Sanfilippo Syndrome: Optimizing Care with a Multidisciplinary Approach.
J Multidiscip Healthc. 2022 Sep 19;15:2097-2110. doi: 10.2147/JMDH.S362994. eCollection 2022.
4
Increasing precision in the measurement of change in pediatric neurodegenerative disease.
Mol Genet Metab. 2022 Sep-Oct;137(1-2):201-209. doi: 10.1016/j.ymgme.2022.09.001. Epub 2022 Sep 8.
5
Caregivers' assessment of meaningful and relevant clinical outcome assessments for Sanfilippo syndrome.
J Patient Rep Outcomes. 2022 Apr 25;6(1):40. doi: 10.1186/s41687-022-00447-w.
6
Parent Experiences of Sanfilippo Syndrome Impact and Unmet Treatment Needs: A Qualitative Assessment.
Neurol Ther. 2021 Jun;10(1):197-212. doi: 10.1007/s40120-020-00226-z. Epub 2020 Dec 2.
7
Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses.
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):121. doi: 10.1186/s13052-018-0561-2.
8
Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III.
Orphanet J Rare Dis. 2017 Jun 26;12(1):117. doi: 10.1186/s13023-017-0675-4.

本文引用的文献

1
Acquired autistic behaviors in children with mucopolysaccharidosis type IIIA.
J Pediatr. 2014 May;164(5):1147-1151.e1. doi: 10.1016/j.jpeds.2014.01.007. Epub 2014 Feb 25.
2
Assessment of sleep in children with mucopolysaccharidosis type III.
PLoS One. 2014 Feb 4;9(2):e84128. doi: 10.1371/journal.pone.0084128. eCollection 2014.
3
Mucopolysaccharidosis Type IIIA presents as a variant of Klüver-Bucy syndrome.
J Clin Exp Neuropsychol. 2013;35(6):608-16. doi: 10.1080/13803395.2013.804035. Epub 2013 Jun 8.
6
Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome).
Orphanet J Rare Dis. 2011 Jun 20;6:43. doi: 10.1186/1750-1172-6-43.
7
Challenging symptom profiles of life-limiting conditions in children: a survey of care professionals and families.
Palliat Med. 2011 Jun;25(4):357-64. doi: 10.1177/0269216310391346. Epub 2011 Jan 12.
9
Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations.
Ann Neurol. 2010 Dec;68(6):876-87. doi: 10.1002/ana.22092.
10
Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype.
J Inherit Metab Dis. 2010 Dec;33(6):759-67. doi: 10.1007/s10545-010-9199-y. Epub 2010 Sep 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验